Browsing Tag
minimal residual disease
2 posts
Can BeOne’s sonrotoclax become the new backbone of B-cell cancer treatment?
Find out how BeOne Medicines’ sonrotoclax is redefining lymphoma and leukemia treatment with new ASH 2025 data.
Adaptive Biotechnologies sees stock surge after clonoSEQ EU certification
In a major development for the biotechnology sector, Adaptive Biotechnologies Corporation witnessed a remarkable 29% surge in its…